Data / Form D filings / Pattern Pharma Inc.
Pattern Pharma Inc.: Form D filings
Pattern Pharma Inc., a pharmaceuticals company in Toronto, Ontario, Canada, filed 11 Form D notices with the SEC between 2018 and 2024. The latest, on August 27, 2024, reports $275,000 sold of a $275,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 199 Bay Street, Suite 4000, Toronto, Ontario, Canada, M5L 1
- Phone
- (416) 302-5155
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1759778
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2024 | New notice | $275,000 | $275,000 | 2 | Feb 15, 2024 | sec.gov | |
| Jul 28, 2021 | Amendment | $1,498,325 | $1,498,325 | 8 | Jul 14, 2021 | sec.gov | |
| Jul 21, 2021 | Amendment | $983,325 | $983,325 | 2 | Jul 6, 2021 | sec.gov | |
| May 26, 2021 | New notice | $150,000 | $150,000 | 1 | May 14, 2021 | sec.gov | |
| May 11, 2021 | Amendment | $1,650,000 | $1,650,000 | 3 | May 4, 2021 | sec.gov | |
| Apr 30, 2021 | New notice | $50,000 | $50,000 | 1 | Apr 16, 2021 | sec.gov | |
| Sep 23, 2020 | Amendment | $570,000 | $570,000 | 2 | Jul 30, 2020 | sec.gov | |
| Aug 12, 2020 | New notice | $500,000 | $500,000 | 1 | Jul 30, 2020 | sec.gov | |
| Jan 15, 2020 | New notice | $100,000 | $100,000 | 1 | Dec 18, 2019 | sec.gov | |
| Dec 13, 2019 | New notice | $75,000 | $75,000 | 1 | Dec 9, 2019 | sec.gov | |
| Nov 27, 2018 | New notice | $40,000 | $40,000 | 2 | Nov 12, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Frans Abeles | Director | |
| Hans Frans Keirstead | Director | |
| Nicholas Frans Glover | Director | |
| Mark Frans van Coeverden de Groot | Executive Officer, Director |
Every Form D from the week of Aug 26, 2024 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pattern Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.